Skip to main content
SpringerLink
Log in

Amphotericin B liposomal/flucytosine

Cardiomyopathy (first report with flucytosine): case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Johnson RE, Campbell-Bright S, Raasch RH, Rodgers JE, Rosenberg BS.Reversible cardiomyopathy following treatment with amphotericin B and flucytosine. International Journal of Antimicrobial Agents 31: 582-584, No. 6, Jun 2008 - USA

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Amphotericin B liposomal/flucytosine. React. Wkly. 1207, 8 (2008). https://doi.org/10.2165/00128415-200812070-00021

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-200812070-00021

Keywords

Search

Navigation